Falsified Medicines Directive: Your Time Starts … Now!
Add bookmark
The Falsified Medicines Directive (FMD) has been labeled as a ‘slow and arduous process to: ‘ratify and may be equally difficult to implement’ (1), with some pharma companies being relatively gradual in the renovation of their product lines. Industry analysts have identified that the major re-engineering demanded for packaging lines is a large, invasive and expensive task - with some questioning as to whether the three year window given will be achievable especially for smaller firms. (1)...
